The Gates Foundation is committing $540 million over 10 years to the Institute for Health Metrics and Evaluation at the University of Washington, strengthening the global infrastructure used to track health trends and guide policy decisions.
The investment comes as public funding for scientific research, education, social services, clean energy and public safety faces growing pressure in the United States.
As governments reassess spending priorities, large philanthropic organizations are increasingly stepping in to support institutions working on critical research and social challenges.
The new grant will support IHME, an independent research organization known for its Global Burden of Disease study. The initiative provides governments, researchers and policymakers with health data used to understand disease patterns, mortality, disability and health outcomes across populations.
Under the expanded program, IHME plans to significantly increase the geographic reach of its research. The Global Burden of Disease study currently covers roughly 925 locations and is expected to expand to nearly 5,000.
The broader coverage could give policymakers access to more localized evidence about where health outcomes are improving, where they are deteriorating and which interventions could have the greatest impact.
“Reliable and independent evidence can mean the difference between reacting to a health crisis after it has taken hold and acting early enough to change its course,” said Dr. Christopher J.L. Murray, director of IHME and professor of health metrics sciences.
According to Murray, the investment will allow IHME to produce high quality evidence at a much more local level, helping leaders make better informed decisions about public health.
The partnership also represents a continuation of a relationship that stretches back nearly two decades. The Gates Foundation provided the founding investment that helped establish IHME at the University of Washington in 2007.
For the Gates Foundation, the commitment fits into a broader strategy centered on global health, poverty reduction and the use of data to improve outcomes.
The foundation has played a significant role in global health initiatives over the past 25 years. Alongside partners, it helped establish Gavi, the Vaccine Alliance, and the Global Fund to Fight AIDS, Tuberculosis and Malaria.
The foundation credits these efforts with contributing to the prevention of millions of deaths and says its investments have helped save 82 million lives since 2000.
Its long term priorities include reducing preventable maternal and child deaths, tackling infectious diseases and helping lift vulnerable communities out of poverty.
The latest commitment comes during a period of significant change for the foundation itself. The organization has announced plans to accelerate its giving and wind down operations by 2045.
That strategy is expected to increase the pace at which the foundation deploys its resources. Bill Gates has said he intends to commit virtually his entire fortune through the foundation, with more than $200 billion expected to be spent by 2045.
The organization announced plans to distribute approximately $9 billion in 2026 as part of the accelerated giving strategy, alongside significant workforce reductions.
The foundation has also faced scrutiny over past interactions between some of its representatives and Jeffrey Epstein, the financier and convicted sex offender who died in 2019.
An external review commissioned by the Gates Foundation found that Bill Gates and foundation staff had met with Epstein more than two dozen times. According to the foundation, the discussions centered on a potential public health fund and a grant involving the International Peace Institute.
The review found no evidence that the Gates Foundation paid Epstein or that the organization participated in or knew about his criminal activities. The foundation has also said it regrets that any of its employees interacted with Epstein.
Despite the controversy, the new IHME investment places the foundation’s global health mission back at the center of attention.
For African governments, researchers and investors, the significance extends beyond the United States. Better health data can influence how governments allocate resources, how development organizations target funding and how investors identify opportunities across healthcare, biotechnology and digital health.
Africa continues to face major gaps in health data infrastructure, particularly at local and subnational levels. More granular evidence could help policymakers move beyond national averages and identify communities where health interventions are most urgently needed.
The IHME expansion therefore reflects a wider shift in global development toward evidence driven decision making. As public funding becomes more constrained in some major economies, philanthropic capital is increasingly helping sustain research that can influence policy far beyond the markets where the money originates.
For the Gates Foundation, the $540 million commitment is both an investment in scientific infrastructure and a continuation of its defining global health mission. For governments and researchers, its value could ultimately depend on how effectively better data is translated into better decisions.
